Who owns johnson and johnson

However, the company still faces thousands of pending lawsuits. In April , a U. District judge from New Jersey made a decision regarding the expert witnesses that can be called by both sides.

The company reiterated its commitment to bring an affordable vaccine to the public on a not-for-profit basis for emergency use during the pandemic. Below are the top five individual shareholders of Johnson and Johnson. As of February 25, , Gorsky holds 2. Gorsky originally joined JNJ back in as a sales representative and rose through the ranks of the company. Joaquin Duato is the second-largest individual shareholder of JNJ with , shares as of February 25, Duato currently serves as the company's executive vice president and worldwide chair, pharmaceuticals, a position he has held since He has been with the company for almost three decades.

Duato is also a board member of the international charity Save the Children. Paulus Stoffels, Ph. Outside of JNJ, Stoffels is a member of the scientific advisory board of Index Life V and specializes in infectious disease treatment and tropical diseases.

Jennifer Taubert is the fourth-largest individual shareholder of JNJ with , shares. Janssen is responsible for innovative pharmaceutical developments, including helping the fight against immune-related diseases, HIV, cancer, heart disease, diabetes, and mental illness.

Wolk with 84, shares. Accessed Oct. Securities and Exchange Commission. Top Stocks. Tech Stocks. Your Privacy Rights. To change or withdraw your consent choices for Investopedia. At any time, you can update your settings through the "EU Privacy" link at the bottom of any page. These choices will be signaled globally to our partners and will not affect browsing data. We and our partners process data to: Actively scan device characteristics for identification.

I Accept Show Purposes. Your Money. Personal Finance. Your Practice. Popular Courses. Investing Stocks. Article Sources. Investopedia requires writers to use primary sources to support their work. N plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest shake-up in the U. The move by the world's largest health products company follows similar announcements by conglomerates Toshiba T General Electric GE.

This has particularly been the case in healthcare, where the slow-and-steady business of selling products such as shampoos and moisturizers has increasingly diverged from the high-risk, high-reward work of developing and marketing blockbuster drugs.

DJI , were up 1. Some analysts argued for investor caution. The U.